Lack of phenotypic alteration of hmUra-DNA glycosylase-deficient hamster cells exposed to DNA-damaging agents.
V79mut1 cells are resistant to the toxic effects of 5-hydroxymethyl-2'-deoxyuridine (hmdUrd) and are deficient in the DNA repair enzyme hydroxymethyluracil-DNA glycosylase (hmUDG). We have therefore proposed that the toxicity of hmdUrd results from the repair of the lesion from DNA. In order to clarify the biological role of hmUDG, we have determined whether the repair-deficient cells showed resistance or sensitivity to the toxic or mutagenic effects of other DNA-damaging agents. Cells were exposed to hmdUrd, ionizing or ultraviolet radiation, to the alkylating agent MNNG, and to oxidative stress produced by hypoxanthine/xanthine oxidase, glucose/glucose oxidase, nitric oxide donor SNAP, or to H2O2. The V79mut1 cells did not show increased mutagenesis in response to hmdUrd. Relative to the V79 parent cells, the V79mut1 cells were not markedly altered in sensitivity to oxidizing agents and ionizing radiation (which produce hmdUra in DNA). The repair-deficient cells wee equally sensitive as the parent V79 cells to DNA damage induced by ultraviolet radiation or by MNNG. No significant differences were seen between the parent and the repair-deficient cells in terms of synthesis of poly(ADP-ribose) in response to damage or in their sensitization to 3-aminobenzamide. Thus, the loss of the 5-hydroxymethyluracil (hmUra)-DNA glycosylase activity in mammalian cells in culture confers no obvious deleterious effect on cell survival or mutagenicity in response to a wide range of DNA damage. These studies indicate that the major lesion known to be repaired by hmUra-DNA glycosylase, an hmUra residue replacing thymine, is produced in cells only in small quantities as the result of exposure to common DNA-damaging agents. These results raise the possibility that hmUra-DNA glycosylase may have evolved to respond to other lesions than hmUra residues formed from the oxidation of thymine.
Mi
L J
LJ
Department of Pathology, Sackler Institute of Graduate Biomedical Sciences, New York University Medical Center, New York, USA.
Mahl
E
E
Chaung
W
W
Boorstein
R J
RJ
D000477:Alkylating Agents / Q000633:toxicity; D000818:Animals; D001549:Benzamides / Q000633:toxicity; D002455:Cell Division / Q000187:drug effects / Q000528:radiation effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D006224:Cricetinae; D004249:DNA Damage; D045647:DNA Glycosylases; D004260:DNA Repair; D004351:Drug Resistance; D005720:Gamma Rays; D006031:Glycosylation; D016296:Mutagenesis / Q000235:genetics; D009152:Mutagenicity Tests; D009153:Mutagens / Q000633:toxicity*; D009699:N-Glycosyl Hydrolases / Q000378:metabolism*; D016877:Oxidants / Q000633:toxicity; D011064:Poly Adenosine Diphosphate Ribose / Q000096:biosynthesis; D013936:Thymidine / Q000031:analogs & derivatives* / Q000633:toxicity; D014466:Ultraviolet Rays
D000477:Alkylating Agents; D001549:Benzamides; D009153:Mutagens; D016877:Oxidants; D011064:Poly Adenosine Diphosphate Ribose; C018080:5-hydroxymethyl-2'-deoxyuridine; C025160:3-aminobenzamide; D045647:DNA Glycosylases; D009699:N-Glycosyl Hydrolases; C041993:hydroxymethyluracil DNA glycosylase; D013936:Thymidine